@drtimos.bsky.social🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVs6b9
@ASCO
#SocialListening #LucidQuest
@drtimos.bsky.social#LucidQuest helps Pharma/Biotech/HealthTech teams turn market signals into decisions, fast.
Start with #QuickAnswers (rapid primary + secondary CI), scale to deeper projects, conference coverage, #LucidWargames simulations, #LucidScope AI narrative audits, and #NexusBrain insight capture.
@drtimos.bsky.social🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TVrf7K | 📧 Talk to experts: [email protected]
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest
@drtimos.bsky.socialLucidQuest YouTube > Gene & Cell Therapy Strategic Roundup | September 1 - October 6, 2026: From 1 September to 6 October 2026, gene and cell therapy developments signaled a shift from technology validation toward proving durable, safe and commercially… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.socialLucidQuest YouTube > Respiratory Strategic Roundup: Earlier Intervention | Sep 04—Oct 07, 2026: The latest edition of the Respiratory Strategic Roundup, covering developments from September 4 to October 7, 2026, highlights a broader shift in respiratory… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚀 Conference coverage to #CGT strategy. #LucidQuest turns congress signals into structured intel: what changed, who it affects, next steps for teams and investors. Previews, recaps, KOLs, CI tracking, decision-ready outputs. 📩 [email protected]
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVqzpq
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.
@drtimos.bsky.social💉 Vaccines & Infectious Diseases 🦠
#LucidQuest equips BioPharma & investors with real-time insights to outpace the curve.
📩 [email protected] or http://dlvr.it/TVqrZB
#Vaccines #InfectiousDiseases #BioPharma #DueDiligence #LifeScienceStrategy
@drtimos.bsky.socialLucidQuest YouTube > Gene & Cell Therapy Strategic Roundup | September 1 - October 6, 2026: From 1 September to 6 October 2026, gene and cell therapy developments signaled a shift from technology validation toward proving durable, safe and commercially… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🧬 Gene & Cell Therapy | #RareDiseases 🚀
#LucidQuest delivers sharp insights to help biotechs, investors & BD teams stay ahead in fast-moving markets.
📩 [email protected] or http://dlvr.it/TVqbST
#GeneTherapy #CellTherapy #Biotech #DueDiligence #InvestmentInsights
@drtimos.bsky.socialMost biopharma launch plans fail not on intent, but on untested response. Competitors counter. Payers retaliate. Regulators reshape rules.
#LucidWargames stress-tests commercial decisions against adversarial behavior, before they’re irreversible.
@drtimos.bsky.socialWin AI search for your brand: structure trials (PMC), align patient portals, publish side-by-sides, frame safety, and own your canonicals.
More: http://dlvr.it/TVqBFN #AIsearch #HealthcareAI #LucidQuest
@drtimos.bsky.socialAI shapes how patients & clinicians find you. Be consistent across sources, make trials citable, answer comparative queries, and audit AI outputs.
Learn how: http://dlvr.it/TVq2kp #AIsearch #HealthTech #LucidQuest
@drtimos.bsky.social🧠 Competitive Insights for #BioPharma and #HealthTech 🚀
#LucidQuest arms #pharma & #biotech with real-time intel to outpace rivals from R&D to market.
📩 [email protected] or http://dlvr.it/TVpnLV
#CompetitiveIntelligence #Strategy #MarketAccess
@drtimos.bsky.social📊 Investment Insights | Advisory | #Fundraising 🚀
At #LucidQuest we help funds & founders turn intelligence into alpha—fast, evidence-based answers before capital moves.
📩 [email protected] or http://dlvr.it/TVpkS8
#VentureCapital #PrivateEquity #HedgeFunds #DealFlow
@drtimos.bsky.social🚀 #DigitalHealth | #AI | #IoE 🌐
At #LucidQuest, we turn bold ideas into patient-centric, AI-powered solutions for #Pharma, #Biotech & #HealthTech.
Let’s shape the future of care together.
📩 [email protected] or
@drtimos.bsky.social👋 CGT and RNA peers, what is the single 90 day challenge blocking you? Share in 60 seconds: http://dlvr.it/TVpCJt
Then join the Gene, Cell and RNA Therapy Strategy Network: http://dlvr.it/TVpCK7
@drtimos.bsky.socialLucidQuest YouTube > Obesity Strategic Roundup | September 1 - October 4, 2026: From September 1 – October 4, 2026, obesity competition expanded beyond headline weight-loss efficacy toward a broader contest involving tolerability, convenience, portfolio… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚀 Contributed to FirstWord report on AI in personalized medicine: smarter trials, faster discovery 🧬💊. Early AI drugs show 80–90% Ph 1 success! 🌍 Challenges remain, but partnerships & continuous learning will drive the future. #LucidQuest
Read more 👉 http://dlvr.it/TVnxtH
@drtimos.bsky.social🚨 Who’s leading BioPharma (+ Google) CVC in 2025?
🔎 #LucidQuest analyzed 22 CVCs—focus by Tech & Therapy Areas + shifts vs. 2023.
Grab the FREE snapshot ⚡